All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Dr. Shaw Discusses Lorlatinib in Lung Cancer | OncLive
May 3, 2018
onclive.com
7:11
Progression Patterns and Subsequent Therapies after Lorlatinib in ALK NSCLC | OncLive
Oct 28, 2024
onclive.com
7:46
Lorlatinib vs Crizotinib in Treatment-Naive Patients With Advanced ALK Non-Small Cell Lung Cancer: 5-Year Progression-Free Survival and Safety From the CROWN Study | OncLive
Jun 17, 2024
onclive.com
0:54
Managing Side Effects of Lorlatinib in Lung Cancer Treatment
719 views
8 months ago
TikTok
alkpositiveinc
Dr. Ramalingam on Avelumab Plus Lorlatinib in NSCLC | OncLive
Jun 23, 2018
onclive.com
1:15
Efficacy Results for Lorlatinib in Patients With ALK-Positive NSCLC
1.7K views
May 4, 2018
YouTube
Targeted Oncology
6:30
Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field Is there a place for Lorlatinib?
351 views
Aug 4, 2017
YouTube
Global Resource for Advancing Cancer Education
0:24
Lorlatinib molecule, anticancer drug,4K
May 21, 2022
Adobe
MedBioChem
'Best' lung cancer drug ever halts tumours giving YEARS to dying patients
May 31, 2024
the-sun.com
0:52
Replying to @user14547730849507 I have ALK and I take lorlatinib (a cousin cancer and treatment of EGFR). #cancer #cancerawareness #lungcancer #raredisease #health
7.4K views
1 month ago
TikTok
mayyapapayya6
8:26
ALK陽性肺癌病患:使用Lorlatinib達到最長無惡化存活時間 ALK-Positive Lung Cancer Patients: Achieving the Longest PFS
3K views
Jul 3, 2024
YouTube
腫瘤科吳教恩醫師
2:37
CROWN: lorlatinib in treatment-naïve patients with ALK-positive advanced NSCLC
1.5K views
Jun 7, 2022
YouTube
VJOncology
8:06
CROWN Trial of 1L Lorlatinib for ALK+ NSCLC - 2025 Targeted Therapies in Lung Cancer Patient Forum
653 views
9 months ago
YouTube
Global Resource for Advancing Cancer Education
Nuovo farmaco contro il tumore ai polmoni per non fumatori: ok dell'Aifa alla rimborsabilità di Lorlatinib
Jan 26, 2024
virgilio.it
3:12
Q&A: New Lesions - Switch from Alectinib to Lorlatinib? Targeted Therapies in Lung Cancer 2023
769 views
Sep 14, 2023
YouTube
Global Resource for Advancing Cancer Education
Optimizing ALK-TKI Sequencing and Neurological Outcomes | OncLive
Nov 1, 2024
onclive.com
Lorbrena (lorlatinib) effetti collaterali, interazioni, usi e impronta di droga - Salute 2026
Aug 21, 2019
oldmedic.com
2:39
ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study
2.6K views
Sep 19, 2020
YouTube
European Society for Medical Oncology (ESMO)
0:57
Virtual rality 🫢Lorbrena (Lorlatinib) – Powerful Pfizer Medicine for Lung Cancer Treatment#trends
499 views
6 months ago
YouTube
HealthOryx USA
3:53
Miracle Tablet Lorlatinib In Lung Cancer #lungcancer #targetedtherapies
398 views
6 months ago
YouTube
Dr. Pratik Patil Oncologist
2:04
Dr. Shaw Discusses Lorlatinib in Lung Cancer
2.5K views
May 2, 2018
YouTube
OncLive
8:45
Synthesis of Drugs: Lorlatinib
1.5K views
Nov 27, 2021
YouTube
Organic Chemistry with Lluís Llorens Palomo
4:49
Part 2: New Drug Brings Hope for a Type of Lung Cancer | Dr. L Rohit Reddy | AI in Healthcare’25
79 views
9 months ago
YouTube
Yashoda Hospitals
3:26
ROS1 Treatment Options: Lorlatinib and Repotrectinib - 2022 Program: Targeted Therapies Forum
418 views
Nov 19, 2022
YouTube
Global Resource for Advancing Cancer Education
1:15:42
ALK 101 Part 5: Life After Lorlatinib
4.8K views
May 1, 2023
YouTube
ALK Positive Inc.
9:27
ALK第三代藥物Lorlatinib:效果與安全性的平衡探討,有效就好? Third-Generation ALK TKI: Balancing Efficacy and Safety
1.8K views
Jul 29, 2024
YouTube
腫瘤科吳教恩醫師
Decoding Efficacy and Safety Outcomes Among Second- and Third-Generation ALK Inhibitors | OncLive
9 months ago
onclive.com
1:46
Is lorlatinib a better option for NSCLC?
1.8K views
Sep 29, 2017
YouTube
VJOncology
8:37
Lorlatinib: La esperanza contra el cáncer de pulmón
6 months ago
TikTok
whiteribbontravels
lorlatinib - Twitch
Mar 30, 2025
twitch.tv
See more
More like this
Feedback